Clinical Trials Browser

Phase 1 × Interventional × MK-4166 × Clear all

NCT02132754 2021-01-28

MK-4166-001

Phase 1 Completed

116 enrolled 61 charts

Other solid neoplasm

Solid Tumor

NCT03707457 2020-07-02

Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma

Phase 1 Terminated

Glioblastoma